Novartis, Roche could be at greater risk
The medications are stored on shelves on a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer |…
Roche Holding AG
Medicaid's cuts in Trump's Megabill will hit some drug manufacturers
The president of the United States, Donald Trump, presents a broad legislation of expenses and prosecutors, known as the “Law…
Trump's pharmaceutical rates feed new investments in the United States
JGI/Jamie Grill | Tetra images | Getty images A version of this article appeared for the first time in the…
Eli Lilly Orforglipron weight loss pill erases the first late stage test
Eli Lilly On Thursday, its daily obesity pill met the company's objectives in the first of several tests in the…
Innovative biotech stocks have a good chance of breaking out in 2025
The trends may be turning in favor of biotech stocks in 2025 after several years of poor performance, but it…
Merck signs weight loss pills licensing agreement with Hansoh Pharma
Exterior view of the entrance to Merck headquarters on February 5, 2024 in Rahway, New Jersey. Spencer Platt | fake…
The agreement with Novo Nordisk Catalent is closer to closing
A view of the Novo Nordisk logo at the company's office in Bagsvaerd, outside Copenhagen, Denmark, on March 8, 2024.…
Novartis CEO says it won't join weight-loss drug frenzy
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
Roche releases more data on slimming pills and injections
Headquarters of Roche, a multinational pharmaceutical industry on December 27, 2021 in Madrid, Spain. Cristina Arias | Cover | Getty…
These drugmakers are catching up to Eli Lilly and Novo Nordisk
The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…